Topics & Speakers
• Evidence Based Management of Sepsis
• Improving Safety and Quality in the ICU
Michael A. Gropper, MD, PhD
• Pneumonia Update, 2007
Scott A. Flanders, MD
• Acute Coronary Syndromes
Edward McNulty, MD
• Management of Stroke Update, 2007
• Neurological Emergencies
S. Andrew Josephson, MD
• Hospital Medicine in 2017: If You Don’t Know Where You’re Going, You Might Not Get There
Robert M. Wachter, MD
• Society of Hospital Medicine (SHM) Update & Discussion
Laurence Wellikson, MD
• Clinical Problem-Solving Exercise
Gurpreet Dhaliwal, MD
• Caught Between a Rock and a Hard Place: Using Evidence to Make Tough Decisions
Scott A. Flanders, MD
Kaveh G. Shojania, MD
• Talking ’Bout a Revolution: Transparency and P4P (Roundtable Discussion)
Peter Lindenauer, MD, MSc
Kaveh G. Shojania, MD
Andrew D. Auerbach, MD, MPH
• Creating a Successful Academic Hospitalist Program
Robert M. Wachter, MD
Scott A. Flanders, MD
• Hospital Information Systems: CPOE, EMRs and More
Peter Lindenauer, MD, MSc
Russell Cucina, MD, MS
• Acute Heart Failure: No Longer the Ugly Duckling
John R. Teerlink, MD
• Diagnosis and Management of Pulmonary Embolism
Leslie Zimmerman, MD
• Management of Common Acute Arrhythmias
Zian H. Tseng, MD
• Management of Upper GI Bleeding
Jonathan P. Terdiman, MD
• Clinical Controversies in Medical Consultation
H. Quinny Cheng, MD
• Hospitalist-Surgical Co-management: Can We Make It Work?
H. Quinny Cheng, MD
Scott A. Flanders, MD
John Maa, MD
Heather Harris, MD
COURSE CHAIR
Robert M. Wachter, MD
Professor of Medicine
Associate Chair, Department of Medicine
Chief of the Medical Service
UCSF Medical Center
San Francisco>
VISITING FACULTY
Scott A. Flanders, MD
Associate Professor of Medicine
Director of the Hospitalist Program, University of Michigan
Kaveh G. Shojania, MD
Assistant Professor of Medicine
Canada Research Chair, Patient Safety and Quality Improvement
University of Ottawa
Peter Lindenauer, MD, MSc
Assistant Professor of Medicine, Tufts University
Medical Director, Clinical Information Systems
Associate Medical Director, Healthcare Quality
Baystate Medical Center
Laurence Wellikson, MD
Chief Executive Officer, Society of Hospital Medicine
Philadelphia, PA
UCSF FACULTY (unless otherwise noted)
Andrew D. Auerbach, MD, MPH
Associate Professor of Medicine
Director of Quality, Department of Medicine
H. Quinny Cheng, MD
Associate Professor of Medicine
Director, Medical Consultation Service
UCSF Medical Center
Russell Cucina, MD, MS
Assistant Professor of Medicine
Associate Medical Director, Clinical Information Technology
UCSF Medical Center
Gurpreet Dhaliwal, MD
Assistant Professor of Medicine
Clerkship Director, SF VA Medical Center
Michael A. Gropper, MD, PhD
Professor of Anesthesia and Physiology
Director, Critical Care Medicine
Heather Harris, MD
Assistant Professor of Medicine
S. Andrew Josephson, MD
Assistant Professor of Neurology
John Maa, MD
Assistant Professor
Department of Surgery
Edward McNulty, MD
Assistant Professor of Medicine
Cardiology Division
John R. Teerlink, MD
Associate Professor of Medicine
Director, Heart Failure Clinic
SF VA Medical Center
Jonathan P. Terdiman, MD
Associate Professor of Medicine
Director, UCSF Colitis and Crohn's Disease Center
Zian H. Tseng, MD
Assistant Professor of Medicine
Division of Cardiology
Electrophysiology Service
Leslie Zimmerman, MD
Professor of Medicine
Director, Bronchoscopy Service
Director, Intensive Care Unit
VA Medical Center
Learning Objectives
At the conclusion of this program, participants will be able to:
- Describe the major diagnoses to be considered in common inpatient
clinical presentations
- Review a modern and evidence-based work-up for common inpatient
clinical presentations
- Discuss modern therapeutic approaches to common inpatient disorders
- List some of the latest literature in the field of hospital medicine and how best to use it to answer clinical questions
Accreditation Statement
The University of California, San Francisco School ofMedicine (UCSF) is accredited by the Accreditation
Council for ContinuingMedical Education (ACCME) to provide continuingmedical education for physicians.
Credit Designation
UCSF designates this educational activity for a maximum of 16.25 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
This CME activity meets the requirements under California Assembly Bill 1195, continuing education and cultural and
linguistic competency. For the purpose of recertification, the American Nurses Credentialing Center accepts AMA PRA Category 1 Credit(s)™ issued by organizations accredited by the ACCME. The California Board of Pharmacy accepts as
continuing professional education those courses that meet the standard of relevance to pharmacy practice and have
been approved for AMA PRA Category 1 Credit(s)™. The approved credits shown above include 1.5 credits towards
meeting the requirement under California Assembly Bill 1820, Geriatric Medicine. The approved credits shown above
include 2.75 AMA PRA Category 1 Credit(s)™ towards meeting the requirement under California Assembly Bill 487,
Pain Management and Care the Terminally Ill.
This educational activity is a DVD format. The activity was planned for hospitalists, internists, family physicians, and
others who care for inpatients. It is estimated that it should take the average learner 16.25 hours, including completion
of the activity evaluation, to conclude the activity.
Release date: February 1, 2008
Credits expire: January 31, 2011
CME credit is obtained upon successful completion of an activity evaluation. A $30 processing fee must accompany the evaluation application.
Faculty Disclosure
Faculty for UCSF’s Continuing Medical Education Program must complete a Declaration
of Disclosure prior to the CME activity. Having an interest in or affiliation with a commercial entity does not
preclude making a presentation at a CME activity, but the relationship must be disclosed in advance and any
potential conflict of interest must be resolved in accordance with the ACCME Updated Standards for Commercial
Support. Disclosure must be conveyed to the learning audience prior to the educational offering; presentation
of information on investigational/off-label use of pharmaceuticals or medical devices must also be disclosed.
Full disclosure of faculty is listed in the syllabus.
|
